- Home
- LEGH vs ORGO Comparison
LEGH vs ORGO Comparison
Compare LEGH & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEGH
- ORGO
- Stock Information
- Founded
- LEGH 2005
- ORGO 1985
- Country
- LEGH United States
- ORGO United States
- Employees
- LEGH N/A
- ORGO N/A
- Industry
- LEGH Homebuilding
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- LEGH Consumer Discretionary
- ORGO Health Care
- Exchange
- LEGH Nasdaq
- ORGO Nasdaq
- Market Cap
- LEGH 588.8M
- ORGO 533.9M
- IPO Year
- LEGH 2018
- ORGO N/A
- Fundamental
- Price
- LEGH $25.28
- ORGO $3.60
- Analyst Decision
- LEGH Buy
- ORGO Buy
- Analyst Count
- LEGH 2
- ORGO 2
- Target Price
- LEGH $29.00
- ORGO $5.50
- AVG Volume (30 Days)
- LEGH 64.7K
- ORGO 1.7M
- Earning Date
- LEGH 05-12-2025
- ORGO 05-08-2025
- Dividend Yield
- LEGH N/A
- ORGO N/A
- EPS Growth
- LEGH 14.29
- ORGO N/A
- EPS
- LEGH 2.48
- ORGO N/A
- Revenue
- LEGH $184,191,000.00
- ORGO $482,043,000.00
- Revenue This Year
- LEGH $3.55
- ORGO $3.31
- Revenue Next Year
- LEGH $8.46
- ORGO $12.50
- P/E Ratio
- LEGH $10.21
- ORGO N/A
- Revenue Growth
- LEGH N/A
- ORGO 11.29
- 52 Week Low
- LEGH $20.55
- ORGO $2.17
- 52 Week High
- LEGH $29.31
- ORGO $6.71
- Technical
- Relative Strength Index (RSI)
- LEGH 57.01
- ORGO 37.36
- Support Level
- LEGH $24.65
- ORGO $5.14
- Resistance Level
- LEGH $25.54
- ORGO $5.55
- Average True Range (ATR)
- LEGH 0.58
- ORGO 0.31
- MACD
- LEGH 0.14
- ORGO -0.01
- Stochastic Oscillator
- LEGH 86.10
- ORGO 0.30
About LEGH Legacy Housing Corporation (TX)
Legacy Housing Corp builds, sell, and finance manufactured homes and tiny houses that are distributed through a network of independent retailers and company-owned stores and also sold directly to manufactured home communities. The company also provides financing options to its customers to facilitate the sale of homes.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.